Atlas Trials

Evaluation of Ivermectin Mucoadhesive Nanosuspension as Nasal Spray in Management of Early Covid-19

Clinical trial NCT04716569 · UNKNOWN

Trial details

NCT number
NCT04716569
Sponsor
South Valley University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Covid19
Start date
2021-01-20
Primary completion
2021-02-20
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.